Table of Content
Executive Summary
Chapter 1 – Introduction
Chapter 2 – Trends in gene editing dealmaking
2.1. Introduction
2.2. Gene editing deals over the years
2.3. Most active gene editing dealmakers
2.4. Gene editing deals by deal type
2.5. Gene editing deals by therapy area
2.6. Gene editing deals by industry sector
2.7. Deal terms for gene editing deals
2.7.1 Gene editing deals headline values
2.7.2 Gene editing deal upfront payments
2.7.3 Gene editing deal milestone payments
2.7.4 Gene editing royalty rates
Chapter 3 – Leading gene editing deals
3.1. Introduction
3.2. Top gene editing deals by value
Chapter 4 – Most active gene editing dealmakers
4.1. Introduction
4.2. Most active gene editing dealmakers
4.3. Most active gene editing deals company profiles
Chapter 5 – Gene editing contracts dealmaking directory
5.1. Introduction
5.2. Gene editing contracts dealmaking directory
Chapter 6 – Gene editing dealmaking by technology type
Deal directory
Deal directory – Gene editing deals by company A-Z
Deal directory – Gene editing deals by deal type
Deal directory – Gene editing deals by therapy area
Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from Current Partnering
?
Table of figures
Figure 1: Gene editing deals since 2016
Figure 2: Active gene editing dealmaking activity – 2016 - 2023
Figure 3: Gene editing deals by deal type since 2016
Figure 4: Gene editing deals by therapy area since 2016
Figure 5: Gene editing deals by industry sector since 2016
Figure 6: Gene editing deals with a headline value
Figure 7: Gene editing deals with an upfront value
Figure 8: Gene editing deals with a milestone value
Figure 9: Gene editing deals with a royalty rate value
Figure 10: Top gene editing deals by value since 2016
Figure 11: Most active gene editing dealmakers 2016 - 2023
Figure 12: Gene editing deals by technology type since 2016